image
Healthcare - Biotechnology - NASDAQ - CH
$ 5.33
0.947 %
$ 223 M
Market Cap
-2.49
P/E
BALANCE SHEET
198 M ASSETS
-24.37%
21.9 M LIABILITIES
-19.08%
176 M EQUITY
-24.98%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Molecular Partners AG
image
Current Assets 192 M
Cash & Short-Term Investments 187 M
Receivables 295 K
Other Current Assets 5.28 M
Non-Current Assets 5.89 M
Long-Term Investments 0
PP&E 5.68 M
Other Non-Current Assets 212 K
Current Liabilities 14.4 M
Accounts Payable 410 K
Short-Term Debt 1.21 M
Other Current Liabilities 12.8 M
Non-Current Liabilities 7.51 M
Long-Term Debt 2.44 M
Other Non-Current Liabilities 5.06 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
ASSETS
Cash & Cash Equivalents 67.3 87.9 71.8 133.7 75.7 99.0 131.3 149.7 195.4 188.4 96.1
Short Term Investments 119.6 161.2 61.0 40.0 19.4 0 9.7 30.5 20.0 0 0
Receivables 0.3 0.5 0 0.2 2.5 51.6 1.2 33 K 1.3 2.9 11.5
Inventory 0 0 (86.7) (0.2) (0.5) (51.6) (9.4) (0.8) 0.1 0.4 (11.5)
Other Current Assets 2.5 3.9 5.7 1.3 2.3 2.7 0.3 0.5 478 0.7 0.1
Total Current Assets 192.5 254.8 164.2 177.8 99.9 153.3 142.5 181.6 216.9 192.0 107.8
PP&E 5.7 7.2 8.1 9.4 4.2 1.5 1.9 2.5 2.5 2.0 2.3
Intangible Assets 0.2 0.3 0.3 0.3 0.8 0.4 27 K 47 K 17.5 K 27.3 K 22.6 K
Goodwill 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0 (7.5) 1 K (9.7) (5.0) 0 0 0 0 0 1
Other Assets 0 0 0 0 0 0 0 0 0 0 0
Total Assets 198.4 262.3 172.7 187.5 104.9 155.2 144.4 184.1 219.4 194.0 110.1
LIABILITIES
Accounts Payable 0.4 1.0 4.9 2.8 2.0 2.1 0.7 1.0 1.2 0.3 0.2
Short Term Debt 1.2 1.2 1.2 1.2 1.3 0 0 0 0 0 0
Other Current Liabilities 12.8 15.1 11.6 9.4 7.0 6.9 4.5 4.3 3.1 3.2 4.0
Total Current Liabilities 14.4 17.3 46.9 57.7 28.6 36.9 14.1 15.8 26.4 22.1 22.7
Long Term Debt 2.4 3.7 4.8 6.0 1.3 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 5.1 2.6 13.7 16.6 20.9 26.6 13.6 32.5 41.2 23.4 1.7
Total Liabilities 21.9 27.1 65.4 80.3 50.8 63.5 27.7 48.3 67.6 45.5 61.8
EQUITY
Common Stock 3.6 3.6 3.2 2.9 2.2 2.1 2.1 2.1 2.0 2.0 1.5
Retained Earnings (191.8) (127.8) (250.9) (195.2) (130.9) (89.9) (60.7) (37.3) (18.0) (17.3) (14.1)
Other Accumulative Comprehensive Income/Loss 0 (1.0) 0 0 0 (6.9) (6.1) (5.1) (4.1) (3.3) (2.5)
Total Equity 176.4 235.2 107.3 107.2 54.1 91.7 116.7 135.8 151.8 148.5 48.3
Total Liabilities and Equity 198.4 262.3 172.7 187.5 104.9 155.2 144.4 184.1 219.4 194.0 110.1
SHARES OUTSTANDING
Common Shares Outstanding 32.8 32.5 31.0 25.0 21.4 21.2 20.9 20.4 19.5 15.2 19.5